The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-12 2024 | Multi-omic analysis in WM: progress being made and challenges that remain
Zachary Hunter, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses the significance of multi-omic analysis in understanding Waldenström’s macroglobulinemia (WM), highlighting both the progress made and the challenges with this technique. He emphasizes how ongoing research is beginning to unveil the complexities of the disease’s evolution and potential therapeutic opportunities. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
